A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)
Projeler > Desteklenmiş Diğer Projeler · 2017
Yazarlar: Tuncay GÖKSEL
2017-2021, Desteklenmiş Diğer Projeler, AR-GE Projesi, Devam Ediyor